Earnings Feed
Start Free
Home/Filings/4/A/0001209191-12-008543
4/A//SEC Filing

Baker Joffre 4/A

Accession 0001209191-12-008543

CIK 0001131324other
View on SEC.govCompany Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 7:51 PM ET

Size

9.1 KB

Accession

0001209191-12-008543

Insider Transaction Report

Form 4/AAmended
Period: 2012-02-05
GENOMIC HEALTH INCGHDX
Baker Joffre
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2012-02-05+2,000→ 133,475 total
  • Award

    Employee Stock Option (right to buy)

    2012-02-05+18,000→ 18,000 total
    Exercise: $29.34Exp: 2022-02-05→ Common Stock (18,000 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    36,113

  • Common Stock

    (indirect: By Trust)
    66,343
Footnotes (3)
  • [F1]Restricted stock units awarded on February 5, 2012, which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014, and 1/3 of the shares on February 15, 2015.
  • [F2]Includes 4,500 restricted stock units awarded January 27, 2011 which vest as to 1/3 of the shares on February 15, 2012, 1/3 of the shares on February 15, 2013 and 1/3 of the shares on February 15, 2014.
  • [F3]The option became exercisable as to 25% of the shares on February 3, 2013, and became exercisable as to 1/48th of the shares each full month thereafter.

Documents

1 file

Issuer

GENOMIC HEALTH INC

CIK 0001131324

→
Entity typeother

Related Parties

1
  • filerCIK 0001337335

Filing Metadata

Form type
4/A
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:51 PM ET
Size
9.1 KB
View on SEC.gov